Friday May 25, 8:00 am Eastern Time
Press Release
SOURCE: Matrix Pharmaceutical, Inc.
Matrix Announces Filing of $30 Million Shelf Registration Statement
FREMONT, Calif., May 25 /PRNewswire/ -- Matrix Pharmaceutical, Inc. (Nasdaq: MATX - news) today announced that it has filed a Form S-3 shelf registration statement with the Securities and Exchange Commission covering up to $30 million in securities of the Company to be offered from time to time. The nature and terms of any offering will be established at the time of sale. The filing of the registration statement provides the Company with the option to sell securities under market conditions at prices deemed in the Company's business interest. The net proceeds are expected to be used to help fund the anticipated launch, if any, of IntraDose® (cisplatin/epinephrine) Injectable Gel, the potential acquisition of new products, capital expenditures and working capital needs.
A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This news release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
A copy of the prospectus, when available, meeting the requirements of Section 10 of the Securities Act of 1933, may be obtained from Matrix Pharmaceutical, Inc., 34700 Campus Drive Fremont, CA 94555, Attention: Vice President, Finance.
Matrix Pharmaceutical, Inc. is headquartered in Fremont, California and has a manufacturing site in San Diego. The Company develops cancer treatments that may improve, extend and save the lives of cancer patients.
This press release contains, in addition to historical statements, certain forward-looking statements. Such statements are based on management's current expectations and are subject to a number of factors and uncertainties. Additional factors and uncertainties which could cause actual results to differ materially from those described in the forward-looking statements are set forth under the heading ``Risk Factors'' in the Company's Annual Report on Form 10-K for the year ended December 31, 2000 and subsequent Form 10-Q's issued in 2001. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Matrix press releases are available at the Matrix web site matx.com . |
